Indica vs Sativa differences: what the newest research reveals about these classifications

Studies from the last decade or so show the sativa vs indica debate may be outdated, and researchers now know that the effects of cannabis depend far more on cannabinoid and terpene chemistry than plant labels.

Key indica vs sativa differences at a glance

• Indica and sativa originally described plant morphology rather than chemistry

• Indica options have historically been linked with relaxation

• Sativa options have historically been linked with energising effects

• Modern research shows cannabinoid and terpene profiles are better predictors of effects

• The vast majority of medical cannabis strains today are hybrids.

Cannabis sativa L. is the scientific name for the cannabis genus, originating from 1753, when Carl Linnaeus classified all cannabis plants under this group in his Species Plantarum. ‘Cannabis’ was classed as the genus, ‘sativa’ as the species, and the ‘L.’ representing Linnaeus’ system. ‘Sativa’ comes from the Latin word ‘sativum’ meaning cultivated.

In 1785, French biologist Jean-Baptiste Lamarck proposed separating cannabis into two distinct species: ‘Cannabis sativa’ and ‘Cannabis indica’, with Indica meaning ‘from India’, one of the regions where it was thought to originate from.

That said, in 2026, most scientists and researchers agree that all cannabis cultivars come from single species with different varieties or subspecies rather than completely separate species. 

All cannabis subspecies (indica, sativa, and ruderalis) can interbreed and produce fertile seeds, which is one of the main biological indicators that they belong to the same species. As a result, the differences commonly associated with these labels tend to reflect plant structure, geographic origin, and chemical composition rather than fundamentally separate botanical species. 

And that is backed up by emerging research, but we will dive into the science a little further on in this article…

Indica vs sativa plant morphology and growth patterns

Click to enlarge image

Feature	Indica (traditional morphology)	Sativa (traditional morphology)
Plant height	Shorter, more compact plants	Taller plants (can exceed 3 to 5 metres outdoors)
Overall structure	Bushy, dense, compact	Tall, airy, more open structure
Internodal spacing	Short spacing between nodes	Longer spacing between nodes
Branching pattern	Dense lateral branching	More spaced, upward branching
Leaf shape	Broad, wide leaflets	Narrow, elongated leaflets
Leaf colour	Darker green	Lighter green
Growth speed	Faster vegetative growth in controlled environments, faster flowering period	Slower initial growth and slower flowering period
Flowering time	Shorter flowering period (typically 8 to 10 weeks)	Longer flowering period (often 12 to 16 weeks)
Resin production	Often high, with dense trichome coverage	Can be high, but more variable
Climate adaptation	Cooler, mountainous regions	Warmer, tropical regions
Mould resistance	Lower due to dense buds	Higher due to airier bud structure
Yield pattern	More consistent, compact yields	Potential for larger yields outdoors

Indica and sativa cannabis cultivars evolved in very different climates, and those environmental pressures shaped how they grow today.

• Indica plants are thought to have originated in the northern regions of the subcontinent and the Middle East, mostly in the mountainous regions of Afghanistan, Pakistan, India, and Tibet.

• Sativa cultivars trace their evolutionary roots back to warmer tropical or subtropical areas of Southeast Asia, Central America, and parts of Africa. 

• Indica plants, especially traditional landrace varieties, are typically shorter and bushier with wider leaves and a tighter flower structure. These plants evolved in colder, harsher climates than their sativa counterparts. 

• As a result, indica cultivars generally have shorter life cycles and faster flowering times, traits that likely developed as adaptations to shorter growing seasons in mountainous environments. 

• Most modern photoperiod indica cultivars finish flower production within 8 to 10 weeks, while sativa cultivars often require 12 to 16 weeks.

• In general terms, indica dominant cultivars produce tighter and denser flower structure while sativa-dominant cultivars typically develop longer, more loosely formed flowers.

• This is thought to be another evolutionary trait, with the looser flower structure of sativa plants helping to lower any chances of mould forming in warmer, more humid tropical climates.

Traditional indica and sativa effect profiles

While modern research does tend to show that sativa effects and indica effects have far more to do with the specific strain's cannabinoid and terpene profiles, these traditional categories are still widely referenced when discussing the overall experiences different cannabis cultivars may offer.

Are indica and sativa really as different as people think?

For more than 220 years, cannabis has been divided into indica and sativa. These labels quickly became a convenient and simple way to describe cannabis plants that evolved in different part of the world. Plants that, while actually being part of the same species, developed distinct physical traits as a result of their environments.

They also became a convenient shorthand for predicting how the effects of a particular cannabis strain might feel. Be that as it may, the full picture is a little more complicated…

Without even considering the evidence that the effects of a cannabis strain are more closely tied to its chemical composition than whether it is labelled sativa or indica, it is important to remember one key point.

Cannabis does not affect everyone in the same way.

The same medical cannabis strains can produce unique therapeutic benefits in different patients. Dose, tolerance, metabolism, and the specific cannabinoid and terpene profile of the product can all influence how a patient responds.

Traditional indica and sativa effect profiles

While modern research does tend to show that sativa effects and indica effects have far more to do with the specific strain's cannabinoid and terpene profiles, these traditional categories are still widely referenced when discussing the overall experiences different cannabis cultivars may offer.

Does indica or sativa feel stronger?

Indica and sativa classifications are not indicators of a strains ‘strength’. The THC content is the main deciding factor on how ‘strong’ a certain cannabis cultivar is considered to be. 

Much of the information on the internet regarding “Does indica or sativa feel stronger?” is actually incorrect. You will often find blogs saying that indica strains produce more THC, or that sativa strains generally have higher levels of CBD, but in this modern market where hybrid strains rule supreme, both of those statements are far too generalised. 

Why do scientists say the indica vs sativa classification is outdated?

Science and research often outpace way we use language, and that could not be more clear than in recreational cannabis culture vs clinically guided and overseen medical cannabis prescribing. 

For decades, the terms indica and sativa have been used as simple shorthand to describe how a particular cannabis strain might feel. But modern research shows these labels do not reliably reflect the chemical make up of the plant.

What are cannabis chemovars?

As cannabis research has evolved, scientists have started using a different way to classify cannabis plants: chemovars.

Chemovar is short for chemical variety. Instead of categorising plants by their physical appearance, such as whether they look like an indica or a sativa, this approach focuses on the chemical compounds the plant produces.

These compounds include cannabinoids such as THC and CBD, along with aromatic molecules called terpenes. Together they create the chemical fingerprint of a cannabis plant.

From a scientific perspective, this fingerprint provides far more useful information than traditional plant labels. Two plants that look different may produce very similar chemical profiles, while plants labelled with the same strain name can vary considerably depending on how they are grown.

For this reason, many researchers prefer chemovar classifications when discussing cannabis varieties.

What are cannabis chemotypes?

Within the chemovar framework, researchers often group cannabis plants into chemical categories known as chemotype.

Chemotypes describe the dominant cannabinoid profile produced by a plant. The most widely recognised cannabis chemotypes are:

• Chemotype I: THC-dominant plants with relatively low CBD levels.

• Chemotype II: Balanced plants that produce both THC and CBD in similar proportions.

• Chemotype III: CBD-dominant plants with very little THC.

These categories help researchers and clinicians describe cannabis varieties based on measurable chemical composition rather than traditional strain labels.  2024 German analysis of commercial cannabis samples identified distinct terpene-based clusters that better explained product characteristics than the traditional indica vs sativa categories. 

What actually determines the effects of a cannabis strain?

In an interview from 2016, Dr Ethan Russo, one of the world-leading researchers in the field of medical cannabis, went so far as to describe the sativa and indica labels as “total nonsense”. 

“There are biochemically distinct strains of Cannabis, but the sativa/indica distinction as commonly applied in the lay literature is total nonsense and an exercise in futility. One cannot in any way currently guess the biochemical content of a given Cannabis plant based on its height, branching, or leaf morphology, “ 

“The degree of interbreeding/hybridization is such that only a biochemical assay tells a potential consumer or scientist what is really in the plant. It is essential that future commerce allows complete and accurate cannabinoid and terpenoid profiles to be available.”

The points Dr Russo made back in 2016 have been consistently backed by the research that has followed.

A 90,000 sample cannabis study challenges the sativa vs indica myth

In 2022, researchers in the United States conducted a large scale chemical analysis of almost 90,000 commercial cannabis samples across six states. What they found was fascinating: indica, sativa and hybrid labels often failed to match the plants’ cannabinoid and terpene composition, highlighting the limitations of these traditional classifications, and the issues around cannabis sectors with lower levels of regulation compared to the UK medical cannabis industry. 

Cannabinoids: THC and CBD ratios

While there have been more than 110 cannabinoids isolated from Cannabis sativa L. plants, the two ‘major cannabinoids’ (that is, the two that are produced in the highest concentration by cannabis cultivars are tetrahydrocannabinol (THC) and cannabidiol (CBD).

These cannabinoids (and one very interesting terpene) have the ability to influence our internal endocannabinoid system, either by directly interacting and binding to the CB1 and CB2 receptors, or by modulating how these receptors respond to the body’s own signalling molecules (called endocannabinoids) and other cannabinoids present in the plant.

As different medical cannabis treatment options (such as THC vapes, medical cannabis oil, or different medical cannabis cultivars) vary widely in their cannabinoid composition, Releaf’s prescribing specialists and clinical team focus on cannabinoid ratios and terpene profiles rather than traditional strain labels when assessing potential treatment options. 

Terpenes and the entourage effect

Click to enlarge image

Terpenes are naturally occurring chemical compounds found in plants (and even produced by some animals) which are responsible for the smell, flavours, and even colours they give off. 

Terpenes are produced by cannabis, but also in an array of other plants and foods, most commonly in aromatic herbs and citrus fruits and are the basic component in essential oils. 

Terpenes are far less discussed than cannabinoids, but they have their own therapeutic properties which contribute to the overall effect of a medical cannabis treatment option, and play a crucial role in what is known as the ‘entourage effect’.

Also put forward by Dr Ethan Russo, the ‘entourage effect’ theory starts with a simple observation: cannabis is not a single chemical, but an ecosystem of compounds. 

Cannabinoids, terpenes, and other molecules interact with each other inside the body, sometimes amplifying or shaping the effects that follow. When these compounds are present as a group rather than in isolation, their combined biological activity may be greater, or simply different, than the effect of any single compound on its own.

Research has found that terpenes mimic cannabinoids and can produce similar therapeutic effects, while other preliminary evidence suggests that some terpenes could have potential benefits for relieving stress, promoting sleep, as an anti-inflammatory agent, and may even lower the chances of unwanted side effects from THC administration.

Common cannabis terpenes and their potential therapeutic effects

What are hybrid cannabis strains?

While “Hybrid strains” (cannabis cultivars that have a mix of genetics from plants that evolved in different climatic regions) can and do sometimes occur naturally, most hybrid strains come from direct human intervention. 

And most UK medical cannabis strains available to patients are hybrid strains. 

Why?

Hybrid strains offer a mix of characteristics from different cannabis lineages. Through selective breeding programs, cannabis cultivators have been able to create cultivars that offer certain desirable traits, such as:

• Growth characteristics

• Cannabinoid profiles

• Terpene ratios 

• Inherent pest and/or disease prevention

• Yield opportunity

• Therapeutic potential

As a result, many cultivars now contain genetics from multiple ancestral plant populations. In practical terms, this means most cannabis products no longer sit neatly within traditional indica or sativa categories. And with modern cannabis genetics being so heavily hybridised, clinicians increasingly focus on a product’s chemical profile rather than its strain label when assessing how it may affect a patient.

Which medical conditions can cannabis help with?

In the UK, a large proportion of patients with a chronic health condition may be potentially eligible for a legal medical cannabis prescription. As long as you have tried at least two conventional treatment options and found they offered little symptom control (or caused unwanted side effects) and have no history of psychosis or bipolar disorder, then you may be eligible for a legal medical cannabis prescription in the UK.

Conditions traditionally linked to indica-dominant chemotypes

While there is limited scientific evidence to support it, Indica dominant strains effects are traditionally thought to be sedative and relaxing. They are known for their physical and full-body effects and may be favoured by those looking for help with: 

• Chronic pain

• Sleep disorders

• Muscle spasticity

• Appetite stimulation

Conditions traditionally linked to sativa-dominant chemotypes

Sativa dominant strains are generally associated with uplifting and energising effects, with consumers often turning to these during the day to enhance creativity, focus, and sociability. These strains may help people look for relief from the symptoms of:

• Depression

• Insomnia

• ADHD

• Anxiety

The above is but a short list of potential conditions that medical cannabis may help with. For a more in-depth look at the conditions Releaf specialists can prescribe medical cannabis for, head to What are the qualifying conditions for a UK medical cannabis prescription?

How do clinicians choose the right cannabis treatment?

There should never be a ’one-size-fits-all’ approach to medical cannabis treatment, as no two patients will react in the same way from the same treatment options. The prescribing specialists that make up Releaf’s world-class clinical team will take all the time needed to review your medical history before your initial consultation. 

Then, during your first appointment, they will discuss your symptoms, previous treatments, current medications, and health goals in detail before recommending a medical cannabis formulation that is in line with your specific needs. A 2023 study examining patient experiences with different cannabis chemotypes found that subjective effects were more closely linked to terpene and cannabinoid profiles than traditional indica or sativa labels.

To learn more about the first steps that new patients take, head to our What to expect in your first six months as a UK medical cannabis patient blog

Frequently asked questions: sativa vs indica in medical cannabis prescribing

What are the potential side effects of medical cannabis?

While most patients do not suffer from heavy side effects when their medical cannabis treatment plan is clinically guided and overseen, you may notice:

• Dry mouth

• Dizziness

• Fatigue

• Increased heart rate

• Appetite changes

If you do experience any side effects, please let your clinical team know. They will help with dosage or treatment option adjustments to help reduce these unwanted effects. 

Is indica better for sleep than sativa?

Yes, indica strains have traditionally been viewed as being better for relaxation and sleep. 

Newer research is showing that this may not always be the case, with the cannabinoid and terpene profile of a specific cultivar being more important than broad classifications such as indica or sativa. 

Does sativa make you more energetic?

Yes, sativa strains have traditionally been seen as offering a more energising effect profile. 

But as with most claims about sativa vs indica strains, the available scientific evidence does not consistently support this claim.

Are indica and sativa labels scientifically accurate?

Many researchers consider indica and sativa labels unreliable for predicting effects, with  both indica and sativa strains belonging to the same species: Cannabis sativa L.

Pre-eminent medical cannabis researcher Dr Ethan Russo described the distinction as “total nonsense” when used to predict chemical composition. Modern research supports this view. Cannabis effects are determined by cannabinoids and terpenes, not plant height or leaf shape.

Can you mix indica and sativa?

Yes, indica and sativa plants can cross-breed and create what are known as ‘Hybrid strains’. You can also mix sativa and indica treatment options in your cannabis flower vaporiser. 

Is indica or sativa better for anxiety?

Cannabis can affect people with anxiety differently depending on the cannabinoid ratio and individual sensitivity. Products containing CBD alongside THC may be considered in certain treatment contexts, with high THC products sometimes increasing levels of anxiety in som patients. 

Again, there is no ‘one-size-fits-all’ treatment routine, so talk with your specialist.

How do I know if sativa or indica (or medical cannabis at all) is right for my condition?

The first thing to understand is that choosing between sativa or indica is just not how medical cannabis treatment decisions are made today. Releaf medical cannabis prescribing focuses on the chemical profile of a product, alongside your symptoms, medical history, and previous treatments.

The easiest way to find out whether medical cannabis could be appropriate for your situation is to complete Releaf’s medical cannabis eligibility checker.

It is free to use, takes less than 20 seconds to complete, and can provide a clear first indication of whether medical cannabis treatment may be suitable for you. If you are eligible, you may then be invited to speak with one of the specialists from Releaf’s world-class clinical team to discuss your symptoms and potential treatment options in more detail.

Releaf - Let’s rethink healthcare